YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival.
Castellano
Isabella
I
Mistrangelo
Massimiliano
M
Crudo
Valentina
V
Chiusa
Luigi
L
Lupo
Rosanna
R
Ricardi
Umberto
U
Morino
Mario
M
Mussa
Antonio
A
Cassoni
Paola
P
D054392:Adipokines; D001005:Anus Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D014408:Biomarkers, Tumor; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D000071451:Chitinase-3-Like Protein 1; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D015972:Gene Expression Regulation, Neoplastic; D006023:Glycoproteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D007558:Italy; D037102:Lectins / Q000378:metabolism*; D008297:Male; D011237:Predictive Value of Tests; D013997:Time Factors
D054392:Adipokines; D014408:Biomarkers, Tumor; C084533:CHI3L1 protein, human; D000071451:Chitinase-3-Like Protein 1; D006023:Glycoproteins; D037102:Lectins